Pharmafile Logo

drug side effects

- PMLiVE

MSD wins key EU approval for Keytruda, Alimta combo

Decision keeps Keytruda well ahead of rival Tecentriq

Sanofi reception

Sanofi gets EU OK for Ablynx flagship drug Cablivi

EMA clears the drug to treat adults with aTTP

- PMLiVE

MHRA cut out of regulatory work as Brexit looms

This year the regulatory body was only awarded two contracts to serve as the lead assessor on NDAs

- PMLiVE

Alnylam gets EU nod for Onpattro amid pricing backlash

However the drug’s price could be lowered in the EU due to direct competition

- PMLiVE

Healthcare Comms news

Owen Health reveals UK pharma's social media ranking, Emotive presents scientific engagement award and Random42 wins a Golden Eagle award

- PMLiVE

May’s Brexit plan cautiously welcomed by biopharma sector

The white paper says the UK should adhere to EMA regulations post-Brexit

- PMLiVE

The Pharma UK Twitter Ranking 2018 [RESEARCH]

The second edition in our Pharma Social Media Series, the UK Twitter Ranking.

An agency called Owen

UK Twitter Hero

The Pharma UK Twitter Ranking 2018 [RESEARCH]

The second edition in our Pharma Social Media Series, the UK Twitter Ranking.

An agency called Owen

Trending: using social media to understand your pharma market

Blue Latitude Health Senior Associate Consultant Jiayi Chen explains how you can use social media to get under the skin of customers and your competition.

Blue Latitude Health

Stepping up in social media: trust and participation are the new imperatives

For marketers the greatest fascination with digital and social engagement is their ability to be tracked and ‘measured’. But let’s be clear on what digital and social can actually deliver....

Brexit Means Brexit

The differential destinations of post-Brexit pharma

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links